For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.

Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.

TitlePublic health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.
Publication TypeJournal Article
Year of Publication2020
AuthorsXie Y, Valdimarsdóttir UA, Wang C, Zhong XR, Gou Q, Zheng H, Deng L, He P, Hu K, Fall K, Fang F, Tamimi RM, Luo T, Lu D
JournalInt J Cancer
Date Published2020 Jul 04
ISSN1097-0215
Abstract

Little is known about how health insurance policies, particularly in developing countries, influence breast cancer prognosis. Here, we examined the association between individual health insurance and breast cancer-specific mortality in China. We included 7436 women diagnosed with invasive breast cancer between 2009 and 2016, at West China Hospital, Sichuan University. The health insurance plan of patient was classified as either urban or rural schemes and was also categorized as reimbursement rate (ie, the covered/total charge) below or above the median. Breast cancer-specific mortality was the primary outcome. Using Cox proportional hazards models, we calculated hazard ratios (HRs) for cancer-specific mortality, contrasting rates among patients with a rural insurance scheme or low reimbursement rate to that of those with an urban insurance scheme or high reimbursement rate, respectively. During a median follow-up of 3.1 years, we identified 326 deaths due to breast cancer. Compared to patients covered by urban insurance schemes, patients covered by rural insurance schemes had a 29% increased cancer-specific mortality (95% CI 0%-65%) after adjusting for demographics, tumor characteristics and treatment modes. Reimbursement rate below the median was associated with a 42% increased rate of cancer-specific mortality (95% CI 11%-82%). Every 10% increase in the reimbursement rate is associated with a 7% (95% CI 2%-12%) reduction in cancer-specific mortality risk, particularly in patients covered by rural insurance schemes (26%, 95% CI 9%-39%). Our findings suggest that underinsured patients face a higher risk of breast cancer-specific mortality in developing countries.

DOI10.1002/ijc.33183
Alternate JournalInt. J. Cancer
PubMed ID32621751
Grant List2017SZ00005 / / Key Research and Development Project of Sichuan Province of China /
2018-00648 / / Swedish Research Council /
Division: 
Epidemiology
Category: 
Faculty Publication